CMS Rule Would Affect Home Infusion Drugs and Inhalation Insulin

A proposed rule to codify guidance for Medicare Part D and sponsor requirements was published by the Center for Medicare & Medicaid Services (CMS) in the May 25 issue of the Federal Register. The new rule addresses clarifications of policies and technical changes associated with Part D, and CMS has been providing similar updates since…